Ueda S - Search Results

1

The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo.

Yoshioka T, Fukuzawa M, Takai Y, Wakamiya N, Ueda S, Kato S, Fujiwara H, Hamaoka T. Yoshioka T, et al. Among authors: ueda s. Cancer Immunol Immunother. 1986;21(3):193-8. doi: 10.1007/BF00199361. Cancer Immunol Immunother. 1986. PMID: 2938736 Free PMC article.

2

Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity.

Wakamiya N, Wang YL, Imai H, Gu HX, Ueda S, Kato S. Wakamiya N, et al. Among authors: ueda s. Cancer Immunol Immunother. 1986;23(2):125-9. doi: 10.1007/BF00199818. Cancer Immunol Immunother. 1986. PMID: 3779714 Free PMC article.

3

The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.

Fujiwara H, Shimizu Y, Takai Y, Wakamiya N, Ueda S, Kato S, Hamaoka T. Fujiwara H, et al. Among authors: ueda s. Eur J Immunol. 1984 Feb;14(2):171-5. doi: 10.1002/eji.1830140212. Eur J Immunol. 1984. PMID: 6199215

4

The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.

Shimizu Y, Fujiwara H, Ueda S, Wakamiya N, Kato S, Hamaoka T. Shimizu Y, et al. Among authors: ueda s. Eur J Immunol. 1984 Sep;14(9):839-43. doi: 10.1002/eji.1830140913. Eur J Immunol. 1984. PMID: 6236991

5

Role of L3T4 antigen in the activation of various functions of Lyt-1+2- T cells against vaccinia virus.

Aoyama A, Yoshioka T, Sato S, Mizushima Y, Ogata M, Ueda S, Kato S, Fujiwara H, Hamaoka T. Aoyama A, et al. Among authors: ueda s. Microbiol Immunol. 1986;30(8):799-810. doi: 10.1111/j.1348-0421.1986.tb03006.x. Microbiol Immunol. 1986. PMID: 2946922 Free article.

6

Additional evidence for the augmented induction of tumor-specific resistance in vaccinia virus-primed mice by immunization with vaccinia virus-modulated syngeneic tumor cells.

Ueda S, Wakamiya N, Wu KS, Kato S, Fujiwara H, Hamaoka T. Ueda S, et al. Biken J. 1984 Mar;27(1):1-7. Biken J. 1984. PMID: 6385960

7

Differential ability of tumor-unique and cross-reactive antigen(s) on two murine hepatoma cell lines to induce Lyt-1+2- T cells responsible for in vivo protective immunity.

Shima J, Yoshioka T, Kosugi A, Ogata M, Fujiwara H, Hamaoka T, Ueda S, Kato S. Shima J, et al. Among authors: ueda s. Biken J. 1987 Mar;30(1):1-8. Biken J. 1987. PMID: 2445335

8

Tumor cells treated with vaccinia virus can activate the alternative pathway of mouse complement.

Wakamiya N, Okada N, Wang YL, Ito T, Ueda S, Kato S, Okada H. Wakamiya N, et al. Among authors: ueda s. Jpn J Cancer Res. 1989 Aug;80(8):765-70. doi: 10.1111/j.1349-7006.1989.tb01712.x. Jpn J Cancer Res. 1989. PMID: 2511185 Free PMC article.

9

Prevention of syngeneic tumor growth in vaccinia virus-primed mice by immunization with vaccinia virus-modulated tumor cells.

Wu KS, Ueda S, Sakaue Y, Ohashi Y, Ikuta K, Sugano T, Kato S. Wu KS, et al. Among authors: ueda s. Biken J. 1981 Dec;24(4):153-8. Biken J. 1981. PMID: 7346041

10

Monoclonal antibodies to cowpox virus: polypeptide analysis of several major antigens.

Kitamoto N, Tanimoto S, Hiroi K, Ozaki M, Miyamoto H, Wakamiya N, Ikuta K, Ueda S, Kato S. Kitamoto N, et al. Among authors: ueda s. J Gen Virol. 1987 Jan;68 ( Pt 1):239-46. doi: 10.1099/0022-1317-68-1-239. J Gen Virol. 1987. PMID: 3806058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,172 results

Search Page

Filters